Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens
Henry O’Donnell, Tia A. Tummino, Conner Bardine, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 23, pp. 17530-17539
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review
Xin Li, Yongcheng Song
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115772-115772
Open Access | Times Cited: 52
The impact of library size and scale of testing on virtual screening
Fangyu Liu, Olivier Mailhot, Isabella Glenn, et al.
Nature Chemical Biology (2025)
Open Access | Times Cited: 5
Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays
Chunlong Ma, Haozhou Tan, Juliana Choza, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 4, pp. 1636-1651
Open Access | Times Cited: 74
Large library docking for novel SARS‐CoV‐2 main protease non‐covalent and covalent inhibitors
Elissa A. Fink, Conner Bardine, Stefan Gahbauer, et al.
Protein Science (2023) Vol. 32, Iss. 8
Open Access | Times Cited: 24
Tackling assay interference associated with small molecules
Lu Tan, Steffen Hirte, Vincenzo Palmacci, et al.
Nature Reviews Chemistry (2024) Vol. 8, Iss. 5, pp. 319-339
Closed Access | Times Cited: 14
CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson’s Disease Associated Protein
Fengling Li, Suzanne Ackloo, C.H. Arrowsmith, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 22, pp. 8521-8536
Open Access | Times Cited: 9
Systematic Reevaluation of Repurposed Drugs Against the Main Protease of SARS‐CoV‐2 via Combined Experiments
Jialu Ye, Rui Zhang, Jiahao Zhou, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access | Times Cited: 1
Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale
Michael A. McCoy, Dominique Spicer, Neil J. Wells, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 10, pp. 7246-7261
Open Access | Times Cited: 24
Improved fluorescence‐based assay for rapid screening and evaluation of SARS‐CoV‐2 main protease inhibitors
Rui Zhang, Haohao Yan, Jiahao Zhou, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Closed Access | Times Cited: 5
Colloidal Aggregation Confounds Cell-Based Covid-19 Antiviral Screens
Isabella Glenn, Lauren N. Hall, Mir M. Khalid, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 10263-10274
Open Access | Times Cited: 5
Structure Activity of β-Amidomethyl Vinyl Sulfones as Covalent Inhibitors of Chikungunya nsP2 Cysteine Protease with Antialphavirus Activity
Anirban Ghoshal, Kesatebrhan Haile Asressu, Mohammad Anwar Hossain, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 16505-16532
Open Access | Times Cited: 5
Manidipine is not a potential inhibitor against SARS-CoV-2 main protease
Rui Zhang, Jiahao Zhou, Haohao Yan, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 3
Open Access | Times Cited: 4
Recent advances of β-catenin small molecule inhibitors for cancer therapy: Current development and future perspectives
Panpan Yang, Yumeng Zhu, Qinwen Zheng, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114789-114789
Closed Access | Times Cited: 18
Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors
Aliakbar Khalili Yazdi, Paknoosh Pakarian, Sumera Perveen, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 8, pp. 1533-1542
Closed Access | Times Cited: 16
Which Small Molecule? Selecting Chemical Probes for Use in Cancer Research and Target Validation
Mary M. Mader, Joachim Rudolph, Ingo V. Hartung, et al.
Cancer Discovery (2023) Vol. 13, Iss. 10, pp. 2150-2165
Open Access | Times Cited: 9
Polyphenolic promiscuity, inflammation-coupled selectivity: Whether PAINs filters mask an antiviral asset
Rick Sheridan, Kevin Spelman
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Characterizing inhibitors of human AP endonuclease 1
L.S. Pidugu, Hardler W. Servius, Spiridon E. Sevdalis, et al.
PLoS ONE (2023) Vol. 18, Iss. 1, pp. e0280526-e0280526
Open Access | Times Cited: 8
Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method
Huijun Zhang, Boqiang Liang, Xiaohong Sang, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 891-891
Open Access | Times Cited: 7
The impact of Library Size and Scale of Testing on Virtual Screening
Fangyu Liu, Olivier Mailhot, Isabella Glenn, et al.
(2024)
Open Access | Times Cited: 2
CACHE Challenge #1: targeting the WDR domain of LRRK2, a Parkinson's Disease associated protein.
Fengling Li, Suzanne Ackloo, C.H. Arrowsmith, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Large library docking for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors
Elissa A. Fink, Conner Bardine, Stefan Gahbauer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 9
Predictions of Colloidal Molecular Aggregation Using AI/ML Models
David C. Kombo, J. David Stepp, Sungtaek Lim, et al.
ACS Omega (2024) Vol. 9, Iss. 26, pp. 28691-28706
Open Access | Times Cited: 1
Invalidating betulinic acid as a potential inhibitor against the main protease of SARS-CoV-2 via combined approaches
Jialu Ye, Tao Xu, Rui Zhang, et al.
Steroids (2024), pp. 109522-109522
Closed Access | Times Cited: 1
Perylene as a controversial antiviral scaffold
Vera A. Alferova, Igor E. Mikhnovets, Alexey A. Chistov, et al.
Annual reports in medicinal chemistry (2022), pp. 93-156
Closed Access | Times Cited: 6
Mapping the Chemical Space of Active‐Site Targeted Covalent Ligands for Protein Tyrosine Phosphatases**
Suk ho Hong, Sarah Y. Xi, Andrew C. Johns, et al.
ChemBioChem (2023) Vol. 24, Iss. 10
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top